Option Care Health, Inc. (NASDAQ:OPCH) Forecasted to Earn FY2024 Earnings of $1.15 Per Share

Option Care Health, Inc. (NASDAQ:OPCH) – Equities research analysts at Barrington Research boosted their FY2024 earnings estimates for Option Care Health in a note issued to investors on Wednesday, April 24th. Barrington Research analyst M. Petusky now anticipates that the company will post earnings of $1.15 per share for the year, up from their prior forecast of $1.10. Barrington Research has a “Outperform” rating and a $38.00 price target on the stock. The consensus estimate for Option Care Health’s current full-year earnings is $1.18 per share. Barrington Research also issued estimates for Option Care Health’s FY2025 earnings at $1.35 EPS.

Option Care Health (NASDAQ:OPCH) last issued its quarterly earnings data on Tuesday, April 23rd. The company reported $0.26 earnings per share for the quarter, topping the consensus estimate of $0.22 by $0.04. Option Care Health had a net margin of 6.15% and a return on equity of 18.92%. The business had revenue of $1.15 billion during the quarter, compared to the consensus estimate of $1.10 billion. During the same quarter in the previous year, the firm earned $0.21 EPS. The company’s revenue was up 12.8% compared to the same quarter last year.

Separately, Jefferies Financial Group boosted their price objective on shares of Option Care Health from $36.00 to $38.00 and gave the company a “buy” rating in a research note on Monday, March 4th.

Option Care Health Stock Performance

Shares of OPCH opened at $29.61 on Friday. The company has a debt-to-equity ratio of 0.74, a quick ratio of 1.33 and a current ratio of 1.77. The stock has a market capitalization of $5.15 billion, a P/E ratio of 19.48, a P/E/G ratio of 1.43 and a beta of 1.22. The company’s fifty day moving average is $31.96 and its two-hundred day moving average is $31.48. Option Care Health has a 1 year low of $24.23 and a 1 year high of $35.74.

Insider Buying and Selling

In other news, Director Harry M. Jansen Kraemer, Jr. bought 35,000 shares of Option Care Health stock in a transaction on Monday, February 26th. The shares were bought at an average cost of $31.55 per share, for a total transaction of $1,104,250.00. Following the acquisition, the director now owns 269,528 shares in the company, valued at $8,503,608.40. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available at this hyperlink. Insiders own 0.64% of the company’s stock.

Institutional Inflows and Outflows

Several large investors have recently modified their holdings of the stock. IFP Advisors Inc grew its position in shares of Option Care Health by 20,350.0% during the third quarter. IFP Advisors Inc now owns 2,454 shares of the company’s stock worth $79,000 after buying an additional 2,442 shares in the last quarter. State of Alaska Department of Revenue grew its holdings in Option Care Health by 4.3% during the third quarter. State of Alaska Department of Revenue now owns 21,376 shares of the company’s stock worth $691,000 after acquiring an additional 880 shares during the period. Exchange Traded Concepts LLC acquired a new position in Option Care Health during the third quarter worth about $812,000. Handelsbanken Fonder AB increased its stake in Option Care Health by 24.3% in the 3rd quarter. Handelsbanken Fonder AB now owns 33,300 shares of the company’s stock worth $1,077,000 after purchasing an additional 6,500 shares in the last quarter. Finally, Sheets Smith Wealth Management increased its stake in Option Care Health by 1.6% in the 3rd quarter. Sheets Smith Wealth Management now owns 32,542 shares of the company’s stock worth $1,053,000 after purchasing an additional 510 shares in the last quarter. 98.05% of the stock is currently owned by hedge funds and other institutional investors.

About Option Care Health

Option Care Health, Inc offers home and alternate site infusion services in the United States. The company provides anti-infective therapies; home infusion services to treat heart failures; home parenteral nutrition and enteral nutrition support services for numerous acute and chronic conditions, such as stroke, cancer, and gastrointestinal diseases; immunoglobulin infusion therapies for the treatment of immune deficiencies; and treatments for chronic inflammatory disorders, including crohn's disease, plaque psoriasis, psoriatic arthritis, rheumatoid arthritis, ulcerative colitis, and other chronic inflammatory disorders.